Ken Griffin Alpha Tau Medical Ltd. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 59,848 shares of DRTS stock, worth $189,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,848Holding current value
$189,718% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.59MCall Options Held
0Put Options Held
0-
Hoyle Cohen, LLC269KShares$853,0080.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$731,3310.0% of portfolio
-
Kovitz Investment Group Partners, LLC226KShares$717,4340.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY223KShares$705,3690.06% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$210,2530.01% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $219M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...